Christopher Luus
Papers
1
Total Citations
88
H-Index
1
About
Christopher Luus is a leading radiochemist whose work has been instrumental in advancing molecular imaging, particularly in the development of novel radiotracers for positron emission tomography (PET). His primary research focuses on the radiosynthesis and application of selective ligands for the translocator protein (TSPO), a key biomarker for neuroinflammation and cancer. Luus's most cited work, "Radiosynthesis of [18F]DPA‐714, a selective radioligand for imaging the translocator protein (18 kDa) with PET" (2008, 88 citations), describes the efficient production of a high-affinity TSPO ligand that has become a cornerstone for preclinical and clinical PET studies. This contribution has enabled researchers to non-invasively visualize inflammatory processes in conditions like Alzheimer's disease, multiple sclerosis, and brain tumors. By optimizing the radiolabeling chemistry, Luus provided the scientific community with a reliable tool for studying neuroimmune responses, significantly impacting the field of neuroimaging. His work exemplifies the critical role of radiochemistry in bridging basic neuroscience and clinical diagnostics, making him a respected figure in the development of targeted PET probes.
Research Focus
Key Achievements
Top Papers
- 1